DI GIORGIO, Angelo
 Distribuzione geografica
Continente #
AS - Asia 1.609
NA - Nord America 1.039
SA - Sud America 496
EU - Europa 341
Continente sconosciuto - Info sul continente non disponibili 246
AF - Africa 37
OC - Oceania 1
Totale 3.769
Nazione #
US - Stati Uniti d'America 996
SG - Singapore 722
BR - Brasile 398
CN - Cina 249
VN - Vietnam 205
HK - Hong Kong 164
IT - Italia 100
BD - Bangladesh 95
RU - Federazione Russa 69
FR - Francia 67
AR - Argentina 48
KR - Corea 48
IN - India 28
MX - Messico 22
DE - Germania 19
EC - Ecuador 19
IQ - Iraq 19
GB - Regno Unito 17
ID - Indonesia 15
PL - Polonia 11
ZA - Sudafrica 11
CL - Cile 10
PK - Pakistan 9
AT - Austria 8
CA - Canada 8
UA - Ucraina 8
NL - Olanda 7
TR - Turchia 7
VE - Venezuela 7
ES - Italia 6
UZ - Uzbekistan 6
CO - Colombia 5
DZ - Algeria 5
EG - Egitto 5
FI - Finlandia 5
LT - Lituania 5
MY - Malesia 5
PY - Paraguay 5
AZ - Azerbaigian 4
GT - Guatemala 4
JP - Giappone 4
MA - Marocco 4
PH - Filippine 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
JO - Giordania 3
NP - Nepal 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
TN - Tunisia 3
BB - Barbados 2
IE - Irlanda 2
IL - Israele 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
MM - Myanmar 1
MN - Mongolia 1
PT - Portogallo 1
SV - El Salvador 1
TG - Togo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.523
Città #
Singapore 240
Hong Kong 162
Ashburn 155
Council Bluffs 111
Dallas 107
Beijing 90
Ho Chi Minh City 75
San Jose 66
Lauterbourg 59
Hanoi 49
Hefei 48
Seoul 48
São Paulo 48
Los Angeles 41
Boardman 30
Redondo Beach 29
New York 28
Buffalo 27
The Dalles 23
Santa Clara 22
Milan 17
Rio de Janeiro 16
Chicago 14
Houston 10
Phoenix 10
Warsaw 10
Curitiba 9
Baghdad 8
Chennai 8
Belo Horizonte 7
Da Nang 7
Denver 7
Frankfurt am Main 7
Orem 7
Thái Bình 7
Amsterdam 6
Atlanta 6
Dhaka 6
Haiphong 6
Hải Dương 6
Manaus 6
Porto Alegre 6
Xi'an 6
Brooklyn 5
Catania 5
Charlotte 5
Johannesburg 5
Joinville 5
Lahore 5
Naples 5
Thái Nguyên 5
Turin 5
Baku 4
Biên Hòa 4
Brasília 4
Buenos Aires 4
Cairo 4
Campinas 4
Des Moines 4
Guayaquil 4
Mexico City 4
Miami 4
Philadelphia 4
Poplar 4
Salvador 4
Stockholm 4
Suzhou 4
Tashkent 4
Tokyo 4
Udine 4
Acireale 3
Addis Ababa 3
Amman 3
Belluno 3
Bengaluru 3
Boston 3
Caxias do Sul 3
City of London 3
Córdoba 3
Erbil 3
Guarulhos 3
Guatemala City 3
Itabira 3
Kuala Lumpur 3
Manchester 3
Montreal 3
Phủ Lý 3
Riyadh 3
Rome 3
San Juan Bautista 3
San Justo 3
Santiago 3
Seattle 3
Sete Lagoas 3
Suzano 3
Turku 3
Uberaba 3
Uberlândia 3
Vienna 3
Vitória da Conquista 3
Totale 1.857
Nome #
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 112
Italian children seem to be spared from the mysterious severe acute hepatitis outbreak: A report by SIGENP Acute Hepatitis Group 76
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 76
A Pediatric Emergency Department Protocol to Avoid Intrahospital Spread of SARS-CoV-2 during the Outbreak in Bergamo, Italy 75
Cardiologic study of 10 patients with Duchenne muscular dystrophy(DMD): personal experience 75
Percutaneous management of chronic total occlusion of the portal vein: a retrospective analysis of technical aspects and outcomes 75
Breakthroughs and challenges in the management of pediatric viral hepatitis 73
Gene Therapy in Patients with the Crigler-Najjar Syndrome 71
Analysis of quality of life, hepatic biochemical markers, and sleep in patients with progressive familial intrahepatic cholestasis who had a pruritus response with odevixibat treatment 69
ABO Incompatible Liver Transplantation in Children: A 20 Year Experience from Centres in the TransplantChild European Reference Network 67
AUTOIMMUNE ACUTE LIVER FAILURE IN CHILDREN: CLINICAL CLUES AND A NEW DIAGNOSTIC SCORE 66
Acute Liver Failure in Children: Is It Time to Revise the Diagnostic Criteria? 64
Cutting edge issues in juvenile sclerosing cholangitis 64
Biliary features in liver histology of children with autoimmune liver disease 64
Foreign Body Ingestion in Children: A 16-year Experience 64
COVID-19 in Children With Liver Disease 63
A child with congenital heart disease and situs viscerum inversus 61
Early steroids after pediatric liver transplantation protect against T-cell-mediated rejection: Results from the ChilSFree study 60
EXTRA-HEPATIC PORTAL VEIN OBSTRUCTION IN CHILDREN: A MULTICENTRE NATIONAL STUDY 60
Disease burden and management of Crigler-Najjar syndrome: Report of a world registry 58
Cold Ischemia Time and Graft Fibrosis Are Associated with Autoantibodies after Pediatric Liver Transplantation: A Retrospective Cohort Study of the European Reference Network TransplantChild 58
Diagnosing Spontaneous Bacterial Peritonitis in Children: Tap-in for Higher Scores 58
Diagnosing Acute Cellular Rejection after Paediatric Liver Transplantation—Is There Room for Interleukin Profiles? 56
Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome 55
Scurvy: A disease of anesthetic interest? Scurvy and anesthesia 54
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 54
Portal Hypertension in Children 54
Munchausen syndrome by proxy 53
Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation Sequencing 51
Paediatric porto-sinusoidal vascular disease: Two different clinical phenotypes with subtle histological differences 51
Long-term Outcome of Asymptomatic Patients with Graft Fibrosis in Protocol Biopsies after Pediatric Liver Transplantation 51
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia 51
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 51
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis 50
Outcome of Very Early Onset Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis: A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN 50
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 49
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis 49
Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome 48
Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic 47
Septic arthritis in infancy with a good outcome: A study of five patients 47
Use of oral vancomycin in children with autoimmune liver disease: A single centre experience 47
Cytomegalovirus-RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof-of-Concept Study 47
Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study 46
Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency 44
Identifying the Aetiology of Acute Liver Failure Is Crucial to Impact Positively on Outcome 44
Outcome of Children with Transjugular Intrahepatic Portosystemic Shunt: A Meta-Analysis of Individual Patient Data 43
Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy 43
Transplant-free Survival in Chronic Liver Disease Presenting as Acute Liver Failure in Childhood 43
Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel 43
The frequency of rare and monogenic diseases in pediatric organ transplant recipients in Italy 43
Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak on Pediatric Liver Transplant Recipients in Lombardy, Northern Italy 42
Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement 42
Reply to comment: Etiology of non-cirrhotic portal vein thrombosis in children: Few or many causes?  42
Successful management of acute liver failure in Italian children: A 16-year experience at a referral centre for paediatric liver transplantation 42
Feasibility and Efficacy of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Children 42
Distinctive Clinical Features of Portal Hypertension in Children with Portal Vein Thrombosis Following Liver Transplantation 42
Health status of children with chronic liver disease during the SARS-CoV-2-outbreak: results from a multicentre study' 41
ODEVIXIBAT TREATMENT IN PATIENTS WITH RECURRENT EPISODIC CHOLESTASIS AND BIALLELIC MUTATIONS IN ATP8B1: A RETROSPECTIVE CASE SERIES 40
Interobserver Agreement on Endoscopic Classification of Oesophageal Varices in Children 40
Longitudinal Immune Phenotype Assessment and Serological Outcome in Foreign-born Children With Chronic Hepatitis B 38
Long-term survival in a child with arthrogryposis multiplex congenita and spinal muscular atrophy 38
Melorheostosis: case report with 20-year follow-up 38
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 37
Long-term Outcome of Transjugular Intrahepatic Portosystemic Shunt in Children With Portal Hypertension 37
Fulminant Hepatic Failure of Autoimmune Aetiology in Children 37
Adeno-associated virus vector mediated gene therapy for Crigler Najjar syndrome: preliminary report of safety and efficacy from the CareCN clinical trial 36
Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children 36
Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP 32
Variability in the management of portal hypertension across European countries: A survey-study by ESPGHAN Portal Hypertension Special Interest Group 32
Odevixibat for Episodic Intrahepatic Cholestasis due to Biallelic Mutations in ATP8B1: A Case Series 32
Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years 29
Diagnosis and management of sclerosing cholangitis and inflammatory bowel disease in children: A survey by SIGENP 25
Portal hypertension 17
Intensive care management of children with liver disease 16
Clinical Course and Outcomes of Paediatric Chronic Hepatitis B: Insights From a Multicenter Longitudinal Cohort of 248 Patients 13
Reply to: “Managing PFIC 7 with odevixibat: Alleviation of pruritus and biochemical response” 10
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 5
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 5
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 5
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 5
Totale 3.769
Categoria #
all - tutte 12.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.017 0 0 0 0 143 30 109 28 86 97 197 327
2025/20262.651 136 380 349 466 289 139 168 114 103 130 223 154
2026/2027101 101 0 0 0 0 0 0 0 0 0 0 0
Totale 3.769